EMEA-001700-PIP01-14

Key facts

Active substance
  • Oxycodone (hydrochloride)
  • naloxone (hydrochloride)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0049/2015
PIP number
EMEA-001700-PIP01-14
Pharmaceutical form(s)
Prolonged-release tablet
Condition(s) / indication(s)
  • Treatment of opioid-induced constipation
  • Treatment of pain
Route(s) of administration
Oral use
Contact for public enquiries
Develco Pharma GmbH
Germany
E-mail: n.burger@develco.ch, k.schmid@develco.ch
Tel. +41 614255020
Fax +41 614255029
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating